Clinical Trial Update: Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Vimseltinib (DCC-3014) for advanced tumors and tenosynovial giant cell tumor (pigmented villonodular synovitis), currently in Phase 1/P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Tendon Sheath
• Malignant Neoplasm
• Pigmented Villonodular Synovitis
• Tenosynovial Giant Cell Tumor
• Tenosynovial Giant Cell Tumor Diffuse

Drugs mentioned

• Vimseltinib (Vimseltinib)

Snippet

Sponsor: Deciphera Pharmaceuticals, LLC | Conditions: Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING